Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22renal+transplantation%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
/vufind/Search/Results?lookfor=%22renal+transplantation%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
Search /vufind/Search2/Results?lookfor=%22renal+transplantation%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
PubPharm (599)
1
Study of safety and efficacy of CFZ533 in kidney transplant patients : A partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability,pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal antibody, CFZ533, in de novo and maintenance kidney transplant recipients (CIRRUS I) - CIRRUS I
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Study of safety and efficacy of CFZ533 in kidney transplant patients : A partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability,pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal antibody, CFZ533, in de novo and maintenance kidney transplant recipients (CIRRUS I) - CIRRUS I
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A study for people who have had a kidney transplant to see the benefits and risks of taking belatacept instead of their current anti-rejection medicine. : Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversionto Nulojix® (belatacept)-based Immunosuppression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Reconstruction and Prediction Modeling of Immune Function in Stable Patients after Renal Transplantation : Establishment and Clinical Application of a Predictive Model for TBNK Distribution in Stable Patients after Renal Transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Reconstruction and Prediction Modeling of Immune Function in Stable Patients after Renal Transplantation : Establishment and Clinical Application of a Predictive Model for TBNK Distribution in Stable Patients after Renal Transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Vaatverkalking na niertransplantatie : Vascular calcification in renal TransplantLines
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Randomized, placebo-controlled study to immunomonitor Mycophenolate mofetil (MMF) in healthy volunteers : Immunomonitoring of MMF
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[60]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
599
Aufsätze
599
E-Artikel
599
E-Ressourcen
Zeitschriftentitel
596
WHO International Clinical Trials Registry Plat...
3
ClinicalTrials.gov
Thema
599
610
Recruitment Status: Not yet recruiting
584
Study Type: Interventional
106
Phase: Phase 4
94
Phase: Phase 2
86
Phase: Phase 3
28
Medical Condition: Renal transplantation MedDRA...
24
Medical Condition: renal transplantation
14
Medical Condition: Prophylaxis of rejection in ...
12
Medical Condition: Prophylaxis of rejection in ...
12
Medical Condition: Renal transplantation MedDRA...
12
Medical Condition: paediatric renal transplant ...
10
Medical Condition: Patients with end stage kidn...
10
Medical Condition: Refractory AMR in adult rena...
10
Study Type: Observational
8
Medical Condition: ESRD (end stage renal diseas...
8
Medical Condition: Evaluation of the efficacy a...
8
Medical Condition: Patients with end stage kidn...
8
Medical Condition: Prophylaxis of kidney allogr...
8
Medical Condition: Renal transplantation
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
164
2020-
435
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
575
Englisch
12
Unbestimmt
10
Spanisch
2
Französisch
Haven't found what you're looking for?
Wird geladen...